CLINICAL_TRIALS
trial_result
· 2024-12-06
Clinical Trial Update: Combined Theta-gamma STN Stimulation for Verbal Fluency in Parkinson Disease [NA]
Summary
The study evaluating combined theta-gamma subthalamic nucleus stimulation to improve verbal fluency in Parkinson's disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Turin, Italy | Conditions: Parkinson Disease | NA | Status: COMPLETED